Letter to the Editor
Acquired long QT syndrome: Risperidone-facilitated triggered activity and Torsades de Pointes during complete AV block. I

https://doi.org/10.1016/j.ijcard.2006.04.084Get rights and content

Abstract

The acquired Long QT Syndrome (aLQTS) is attributed to subtle defects in genes encoding potassium currents (Ik) that may become clinically significant when associated with other factors that impair ventricular repolarization, such as female gender, bradycardia, hypokalemia or the administration of ion channel blocking drugs. We describe full exposure of an aLQTS in a elderly female patient on long-term Risperidone treatment just when bradycardia due to complete AV block developed. We postulate that the aLQTS induced is the result of a combined block of the rapid (IKr)and delayed (IKs) components of the Ik current. The electrocardiographic manifestation of (likely) phase 2 early afterdepolarizations and a critical transmural dispersion of repolarization (TDR), both required for the initiation and maintenance of the polymorphic ventricular tachycardia associated with the syndrome (Torsades de Pointes), are as well shown.

Risperidone should be used with caution in female patients prone to bradycardia.

References (23)

  • F.G. Akar et al.

    Unique topographical distribution of M cells underlies reentrant mechanism of Torsade de Pointes in the Long-QT Syndrome

    Circulation

    (2002)
  • Cited by (17)

    • Transgenic rabbit models to investigate the cardiac ion channel disease long QT syndrome

      2016, Progress in Biophysics and Molecular Biology
      Citation Excerpt :

      The occurrence of AV conduction block is infrequent but associated with elevated arrhythmogenic risk (Gorgels et al., 1998; Pruvot et al., 1999; Rosenbaum and Acunzo, 1991; Sakaguchi et al., 2008). Similarly, in acquired LQTS, AV block may trigger polymorphic VTs (Chevalier et al., 2007; Raviρa et al., 2007). As in human LQTS patients, slow heart rates, short-long-short sequences, bigeminy, and R-on-T phenomena were recorded prior to sustained and non-sustained VT in LQT2 rabbits (Brunner et al., 2008).

    • Multifocal atrial tachycardia caused by risperidone

      2016, International Journal of Cardiology
    • Risperidone unmasking an accessory pathway

      2015, International Journal of Cardiology
    • ECG parameters in children and adolescents treated with aripiprazole and risperidone

      2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry
      Citation Excerpt :

      Risperidone has been shown in vitro to cause delayed ventricular repolarization in human myocardial cells (Gluais et al., 2004). Some studies in adults have shown small, but significant degrees of QTc prolongation with risperidone (Raviña et al., 2007; Suzuki et al., 2012) whereas others with a larger cohort documented no prolongation at regular doses (Chiu et al., 2005). Two earlier studies did not find risperidone-induced QT changes in pediatric patients (de Castro et al., 2008; Nahshoni et al., 2007).

    • Prevention of Torsade de Pointes in Hospital Settings. A Scientific Statement From the American Heart Association and the American College of Cardiology Foundation Endorsed by the American Association of Critical-Care Nurses and the International Society for Computerized Electrocardiology

      2010, Journal of the American College of Cardiology
      Citation Excerpt :

      Bradycardia is an additional important risk factor for TdP in patients when other predisposing findings are present (65,87). Prolonged ventricular cycle length can take the form of simple sinus bradycardia, complete atrioventricular block, or any rhythm in which sudden long cycles may lead to arrhythmogenic early afterdepolarizations (98,99). Premature beats that lead to short-long-short cycles may foster the development of TdP (65,72).

    • Antipsychotic drugs

      2010, Side Effects of Drugs Annual
      Citation Excerpt :

      Both drugs were commonly associated with adverse events and high attrition rates. Acquired long QT syndrome associated with risperidone has again been reported (182A). An 83-year-old woman with senile dementia and psychosis, who had taken risperidone 1.5 mg/day for the past 2 years and was also taking diltiazem 120 mg/day and torasemide 5 mg/day, developed a slow pulse.

    View all citing articles on Scopus
    View full text